BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Everolimus
1
Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope
3/28/2024 12:17:56 PM | Browse: 349 | Download: 905
2
Pneumocystis jirovecii diagnosed by next-generation sequencing of bronchoscopic alveolar lavage fluid: A case report and review of literature
2/6/2023 6:38:44 AM | Browse: 446 | Download: 1416
3
Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature
10/21/2022 2:24:59 AM | Browse: 595 | Download: 1655
4
Current aspects of renal dysfunction after liver transplantation
1/21/2022 8:16:14 AM | Browse: 887 | Download: 1974
5
Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - An update on neuroendocrine neoplasm’s treatment: A case report
5/20/2021 3:14:20 PM | Browse: 892 | Download: 2482
6
Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario
12/17/2020 9:42:32 AM | Browse: 985 | Download: 2415
7
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
12/21/2018 1:32:15 AM | Browse: 1324 | Download: 1788
8
Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
9/7/2018 6:15:25 AM | Browse: 1245 | Download: 2156
9
Use of everolimus in liver transplantation
8/18/2017 1:45:25 AM | Browse: 1457 | Download: 2017
10
Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation
6/20/2017 12:12:53 PM | Browse: 1337 | Download: 2503
11
Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate
4/7/2017 8:24:12 AM | Browse: 1391 | Download: 2165
12
Growth hormone abolishes the negative effects of everolimus on intestinal wound healing
4/29/2016 4:50:00 PM | Browse: 1694 | Download: 3265
13
Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale?
4/7/2016 11:01:00 AM | Browse: 1380 | Download: 2382
14
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours
3/30/2016 2:15:00 PM | Browse: 1599 | Download: 2247
15
Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis
3/21/2016 8:54:00 AM | Browse: 1369 | Download: 2171
16
Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation
3/18/2016 2:28:00 PM | Browse: 1622 | Download: 2542
17
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
12/23/2015 8:26:00 AM | Browse: 1575 | Download: 2850
18
Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful
12/23/2015 8:26:00 AM | Browse: 1435 | Download: 3279
19
Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center
12/23/2015 8:26:00 AM | Browse: 1789 | Download: 3854
20
Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic
12/9/2015 6:37:00 PM | Browse: 1504 | Download: 2353
21
Mammalian target of rapamycin inhibition in hepatocellular carcinoma
12/2/2015 12:16:00 PM | Browse: 1445 | Download: 1928
22
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1630 | Download: 2346
23
Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions
12/11/2014 2:06:00 PM | Browse: 1415 | Download: 1956
24
Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors
11/17/2014 3:13:00 PM | Browse: 1289 | Download: 1984
25
Hepatitis B reactivation related to everolimus
9/10/2014 3:18:00 PM | Browse: 1332 | Download: 961
26
Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients
8/25/2014 9:54:00 AM | Browse: 1211 | Download: 1703
27
Multiple indications for everolimus after liver transplantation in current clinical practice
8/25/2014 9:54:00 AM | Browse: 1310 | Download: 1556